Abstract
The development of psychotherapy has been based on psychological theories and clinical effects. However, an investigation of the neurobiological mechanisms of psychological interventions is also needed in order to improve indication and prognosis, inform the choice of parallel pharmacotherapy, provide outcome measures and potentially even aid the development of new treatment protocols. This neurobiological investigation can be informed by animal models, for example of learning and conditioning, but will essentially need the non-invasive techniques of functional neuroimaging in order to assess psychotherapy effects on patients’ brains, which will be reviewed here. Most research so far has been conducted in obsessive compulsive disorder (OCD), anxiety disorders and depression. Effects in OCD were particularly exciting in that both cognitive behavioural therapy and medication with a selective serotonin inhibitor led to a reduction in blood flow in the caudate nucleus. In phobia, brief courses of behavioural therapy produced marked reductions of paralimbic responses to offensive stimuli in line with the clinical improvement. Findings in depression are less consistent, with both increases and decreases in prefrontal metabolism being reported. However, they are important in pointing to different mechanisms for the clinical effects of pharmacotherapy (more “bottom up”) and psychotherapy (more “top down”). For the future it would be desirable if the findings of psychotherapy changes to brain activation patterns were confirmed in larger groups with homogenous imaging protocols. Functional imaging has already made great contributions to the understanding of the neural correlates of psychopathology. For example, evidence converges to suggest that the subgenual cingulate is crucial for mood regulation. One current clinical application of these findings is deep brain stimulation in areas highlighted by such imaging studies. I will discuss their initial application in depression and OCD, and suggest potential alternative options based on recent developments in neurofeedback technology.
Similar content being viewed by others
References
Bandura A, Adams N, Beyer J (1977) Cognitive processes mediating behavioral change. J Pers Soc Psychol 35:125–139
Baxter LJ, Schwartz J, Bergman K, Szuba M, Guze B, Mazziotta J, Alazraki A, Selin C, Ferng H, Munford P (1992) Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 49:681–689
Beutel M, Huber M (2008) Can it contribute to our understanding of processes of change? Neuropsychoanalysis (in press)
Beyer J, Krishnan K (2002) Volumetric brain imaging findings in mood disorders. Bipolar Disord 4:89–104
de Charms R (2007) Reading and controlling human brain activation using real-time functional magnetic resonance imaging. Trends Cogn Sci 11:473–481
de Charms R, Maeda F, Glover G, Ludlow D, Pauly J, Soneji D, Gabrieli J, Mackey S (2005) Control over brain activation and pain learned by using real-time functional MRI. Proc Natl Acad Sci U S A 102:18626–18631
DeFelipe J (2006) Brain plasticity and mental processes: Cajal again. Nat Rev Neurosci 7:811–817
Dierks T, Linden D, Jandl M, Formisano E, Goebel R, Lanfermann H, Singer W (1999) Activation of Heschl’s gyrus during auditory hallucinations. Neuron 22:615–621
Dilger S, Straube T, Mentzel H, Fitzek C, Reichenbach J, Hecht H, Krieschel S, Gutberlet I, Miltner W (2003) Brain activation to phobia-related pictures in spider phobic humans: an event-related functional magnetic resonance imaging study. Neurosci Lett 348:29–32
Drevets W, Gadde K, Krishnan K (2004) Neuroimaging studies of mood disorders. In: Charney D, Nestler E (eds) Neurobiology of mental illness. University Press, Oxford, pp 461–490
Drevets W, Price J, Simpson JJ, Todd R, Reich T, Vannier M, Raichle M (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386:824–827
Furmark T, Tillfors M, Marteinsdottir I, Fischer H, Pissiota A, Långström B, Fredrikson M (2002) Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 59:425–433
Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H (2004) Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61:34–41
Hofbauer R, Rainville P, Duncan G, Bushnell M (2001) Cortical representation of the sensory dimension of pain. J Neurophysiol 86:402–411
Hoffman R, Hawkins K, Gueorguieva R, Boutros N, Rachid F, Carroll K, Krystal J (2003) Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry 60:49–56
Jandl M, Steyer J, Weber M, Linden D, Rothmeier J, Maurer K, Kaschka W (2006) Treating auditory hallucinations by transcranial magnetic stimulation: a randomized controlled cross-over trial. Neuropsychobiology 53:63–69
Kennedy S, Konarski J, Segal Z, Lau M, Bieling P, McIntyre R, Mayberg H (2007) Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 164:778–788
Linden D (2008) Changing the mind, changing the brain. Neuropsychoanalysis (in press)
Linden D (2006) How psychotherapy changes the brain-the contribution of functional neuroimaging. Mol Psychiatry 11:528–538
Mayberg H, Lozano A, Voon V, McNeely H, Seminowicz D, Hamani C, Schwalb J, Kennedy S (2005) Deep brain stimulation for treatment-resistant depression. Neuron 45:651–660
Paquette V, Lévesque J, Mensour B, Leroux J, Beaudoin G, Bourgouin P, Beauregard M (2003) “Change the mind and you change the brain”: effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage 18:401–409
Rainville P, Duncan G, Price D, Carrier B, Bushnell M (1997) Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 277:968–971
Röder C, Michal M, Overbeck G, van de Ven V, Linden D (2007) Pain response in depersonalization: a functional imaging study using hypnosis in healthy subjects. Psychother Psychosom 76:115–121
Schienle A, Schäfer A, Hermann A, Rohrmann S, Vaitl D (2007) Symptom provocation and reduction in patients suffering from spider phobia: an fMRI study on exposure therapy. Eur Arch Psychiatry Clin Neurosci 257:486–493
Shapira N, Liu Y, He A, Bradley M, Lessig M, James G, Stein D, Lang P, Goodman W (2003) Brain activation by disgust-inducing pictures in obsessive-compulsive disorder. Biol Psychiatry 54:751–756
Sireteanu R, Oertel V, Mohr H, Haenschel C, Linden D, Maurer K, Singer W, Schwarz M (2008) Graphical illustration and functional neuroimaging of visual hallucinations during prolonged blindfolding: a comparison to visual imagery. J Vision 8:68a
Straube T, Glauer M, Dilger S, Mentzel H, Miltner W (2006) Effects of cognitive-behavioral therapy on brain activation in specific phobia. Neuroimage 29:125–135
Weiskopf N, Sitaram R, Josephs O, Veit R, Scharnowski F, Goebel R, Birbaumer N, Deichmann R, Mathiak K (2007) Real-time functional magnetic resonance imaging: methods and applications. Magn Reson Imaging 25:989–1003
Conflict of interest statement
The author has received honoraria for a book chapter by the Schattauer Verlag.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Linden, D.E.J. Brain imaging and psychotherapy: methodological considerations and practical implications. Eur Arch Psychiatry Clin Neurosci 258 (Suppl 5), 71–75 (2008). https://doi.org/10.1007/s00406-008-5023-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-008-5023-1